Rituximab Therapy for Autoimmune Hemolytic Anemia and Immune Thrombocytopenia: A Belgian Registry.

Daan Dierickx,Philippe Mineur,Agnes Triffet,Alain Kentos, Carine Keppens,Pascal Pierre,Alina Ferster,Dominique Boulet,Christiane Vermylen,Bernard Deprijk,Yves Beghin,Marie-France Dresse,Khalil Kargar,Greet Bries,Gregor Verhoef,Andre Delannoy

Blood（2007）

引用 1|浏览20

暂无评分

摘要

Background. Immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AIHA) may respond to the chimeric anti-CD20 monoclonal antibody rituximab, even when refractory to conventional therapy.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要